![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Liver Cirrhosis |
|
Free Subscription
1 Clin Res Hepatol Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
Clin Res Hepatol Gastroenterol
Endoscopic Sleeve Gastroplasty for Super Morbid Obesity in Compensated Liver
Cirrhosis: Expanding Minimally Invasive Options for High?Risk Patients.
Clin Res Hepatol Gastroenterol. 2026 Aug 18:102908.
PubMed
Placebo-Arm Cirrhosis Incidence in Fibrotic MASH: A Trial-Based Benchmark.
Dig Dis Sci. 2026 Aug 21. doi: 10.1007/s10620-026-10189.
PubMed
Higher Off-Therapy Relapse Risk with Tenofovir Alafenamide than Entecavir in
Non-cirrhotic HBeAg-Negative Chronic Hepatitis B: Insights from End-of-Treatment
qHBsAg Stratification.
Dig Dis Sci. 2026 Aug 18. doi: 10.1007/s10620-026-10188.
PubMed
Abstract available
Carvedilol Continues to Win: A Target Trial Emulation Study Comparing Carvedilol
Against Other Nonselective B-Blockers in Cirrhosis.
Gastroenterology. 2026 Aug 21:S0016-5085(26)07183.
PubMed
Reply to "Rifaximin and the DCA-serotonin axis in cirrhotic portal hypertension:
how much of the benefit is bile-acid specific?".
J Hepatol. 2026 Aug 21:S0168-8278(26)02858-8. doi: 10.1016/j.jhep.2026.
PubMed
EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world
evidence in primary biliary cholangitis.
J Hepatol. 2026 May 27:S0168-8278(26)00193-5. doi: 10.1016/j.jhep.2026.
PubMed
Abstract available
A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular
Carcinoma.
J Hepatol. 2026 May 6:S0168-8278(26)00215-1. doi: 10.1016/j.jhep.2026.
PubMed
Abstract available
Aspects of implementing a nurse-based follow-up of patients with liver cirrhosis:
A qualitative study.
PLoS One. 2026;21:e0356782.
PubMed
Abstract available
Macrophages diverge into profibrotic SAMs and proresolving ReM2 cells to regulate
liver fibrosis.
Proc Natl Acad Sci U S A. 2026;123:e2611441123.
PubMed
Abstract available
CXCR4-targeted dual softener for inducing senescence therapy in hepatic fibrosis.
Proc Natl Acad Sci U S A. 2026;123:e2600215123.
PubMed
Abstract available
Successful Heart and Renal Allograft Transplantation From Patients With
Child-Pugh Class C Cirrhosis.
Transplant Proc. 2026 Aug 19:S0041-1345(26)00376.
PubMed
Abstract available
Multidisciplinary Team Approach to the Management of Early Esophageal
Adenocarcinoma in a Patient with Liver Cirrhosis, Portal Hypertension, and Severe
Thrombocytopenia.
Z Gastroenterol. 2026 Aug 18. doi: 10.1055/a-2857-7509.
PubMed
Abstract available
Thank you for your interest in scientific medicine.